Pentraxin-3 (PTX3), a newly identified pro-atherosclerotic marker in SLE, is synthesized by mononuclear phagocytes, myeloid-derived dendritic cells and endothelium cells as a response to local inflammation. The gene discussed is PTX3; the disease is systemic lupus erythematosus.